# Glucagon in the treatment of cardiogenic shock following acute myocardial infarction.

> PubMed lists PMID 4727938 in Journal of the Irish Medical Association as Journal Article, with publication-date metadata of 1973-08-11 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-4727938-glucagon:v1`
- Evidence domain: Literature metadata
- Date in source: 2004-11-17
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-4727938-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-4727938-glucagon-v1.json
- Content SHA-256: `d90bff4425c9b9e0e46c8dfb63befc3360f410da3c36d9b428f71daa4114ebbd`

## Claims and source pins

### Headline

Glucagon in the treatment of cardiogenic shock following acute myocardial infarction. ([`pubmed-observation-pmid-4727938-2004-11-17-64f0fe08c66c`](#source-pubmed-observation-pmid-4727938-2004-11-17-64f0fe08c66c))

### Summary

PubMed lists PMID 4727938 in Journal of the Irish Medical Association as Journal Article, with publication-date metadata of 1973-08-11 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-4727938-2004-11-17-64f0fe08c66c`](#source-pubmed-observation-pmid-4727938-2004-11-17-64f0fe08c66c))

### Paragraph 1

PubMed lists PMID 4727938 in Journal of the Irish Medical Association as Journal Article, with publication-date metadata of 1973-08-11 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-4727938-2004-11-17-64f0fe08c66c`](#source-pubmed-observation-pmid-4727938-2004-11-17-64f0fe08c66c))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-4727938-2004-11-17-64f0fe08c66c`](#source-pubmed-observation-pmid-4727938-2004-11-17-64f0fe08c66c))

## Sources

<a id="source-pubmed-observation-pmid-4727938-2004-11-17-64f0fe08c66c"></a>
- **Glucagon in the treatment of cardiogenic shock following acute myocardial infarction. · retained source version 1:2004-11-17:current:64f0fe08c66c3a02ffb4735622dc19002fa22e3c0c55919222877498cd7e3b71** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/4727938/) (`pubmed-observation-pmid-4727938-2004-11-17-64f0fe08c66c`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Glucagon in the treatment of cardiogenic shock following acute myocardial infarction." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-4727938-glucagon-v1.json SHA-256: d90bff4425c9b9e0e46c8dfb63befc3360f410da3c36d9b428f71daa4114ebbd.